This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dubey, R. K. Articles by Jackson, E. K. Search for Related Content PubMed PubMed Citation Articles by Dubey, R. K. Articles by Jackson, E. K.

(Hypertension. 1996;27:766-773.)
© 1996 American Heart Association, Inc.

Articles

Smooth Muscle Cell–Derived Adenosine Inhibits Cell Growth

Raghvendra K. Dubey; Delbert G. Gillespie; Zaichuan Mi; Fumio Suzuki; Edwin K. Jackson

From the Center for Clinical Pharmacology, Departments of Medicine (R.K.D., D.G.G., Z.M.) and Pharmacology (E.K.J.), University of Pittsburgh (Pa) Medical Center, and Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co, Sunto-Gun, Shizuoka-Ken, Japan (F.S.).

Correspondence to Dr Raghvendra K. Dubey, Center for Clinical Pharmacology, Department of Medicine, 623 Scaife Hall, 200 Lothrop St, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2582.

Abstract Several endogenous factors generated within the vessel wall have been implicated in contributing to the vascular remodeling process associated with hypertension and atherosclerosis. Furthermore, substances generated by smooth muscle cells (SMCs) are known to regulate SMC proliferation in an autocrine fashion. Adenosine is a vasodilator synthesized by SMCs, and exogenous adenosine inhibits SMC proliferation. However, whether adenosine produced endogenously has antimitogenic effects is not known. Hence, we evaluated the effects of SMC-derived adenosine on 2.5% fetal calf serum–induced proliferation of rat aortic SMCs. SMC proliferation was assayed by measurement of DNA synthesis ([³H]thymidine incorporation) and cell counting. To determine the effects of endogenous adenosine on SMC proliferation, we stimulated growth-arrested SMCs with 2.5% fetal calf serum in the presence and absence of modulators of adenosine levels, including (1) erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA; inhibits adenosine deaminase), (2) dipyridamole (blocks adenosine transport and inhibits phosphodiesterase), (3) dipyridamole plus EHNA, and (4) adenosine with or without EHNA. [³H]Thymidine incorporation and cell number were measured after 24 and 96 hours, respectively. EHNA and dipyridamole inhibited both FCS-induced DNA synthesis and cell proliferation in a concentration-dependent manner. Furthermore, extracellular (in medium) adenosine levels were significantly increased when cultured cells were treated with EHNA, and the inhibitory effects of dipyridamole as well as exogenous adenosine were enhanced in the presence of EHNA. Additionally, the inhibitory effects of dipyridamole and EHNA on DNA synthesis were significantly reduced in the presence of KF17837, an A₂ adenosine receptor antagonist. These results indicate that SMC-derived adenosine can inhibit SMC proliferation. Hence, it is possible that a defect in localized adenosine synthesis within the vessel wall could contribute to vascular thickening and neointima formation.

Key Words: adenosine • muscle, smooth, vascular • atherosclerosis • hyperplasia • neointima

This article has been cited by other articles:

				R. C. Tostes, F. R. C. Giachini, F. S. Carneiro, R. Leite, E. W. Inscho, and R. C. Webb Determination of Adenosine Effects and Adenosine Receptors in Murine Corpus Cavernosum J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 678 - 685. [Abstract] [Full Text] [PDF]

				B. S Dixon, G. J Beck, L. M Dember, T. A Depner, J. J Gassman, T. Greene, J. Himmelfar, L. G Hunsicker, J. S Kaufman, J. H Lawson, et al. Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial Clinical Trials, October 1, 2005; 2(5): 400 - 412. [Abstract] [PDF]

				J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor Circ. Res., September 16, 2005; 97(6): 574 - 582. [Abstract] [Full Text] [PDF]

				G. P. H. Leung, R. Y. K. Man, and C.-M. Tse D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2756 - H2762. [Abstract] [Full Text] [PDF]

				J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Novel Mitogenic Effect of Adenosine on Coronary Artery Smooth Muscle Cells: Role for the A1 Adenosine Receptor Circ. Res., May 13, 2005; 96(9): 982 - 990. [Abstract] [Full Text] [PDF]

				N. P. Riksen, G. A. Rongen, H. J. Blom, F. G.M. Russel, G. H.J. Boers, and P. Smits Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia Cardiovasc Res, August 1, 2003; 59(2): 271 - 276. [Abstract] [Full Text] [PDF]

				E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]

				S. J. Mundell, M. E. Olah, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn Regulation of G Protein-Coupled Receptor-Adenylyl Cyclase Responsiveness in Human Airway Smooth Muscle by Exogenous and Autocrine Adenosine Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 155 - 163. [Abstract] [Full Text]

				S. Mattig and A. Deussen Significance of adenosine metabolism of coronary smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H117 - H124. [Abstract] [Full Text] [PDF]

				M.-L. Peyot, A.-P. Gadeau, F. Dandre, I. Belloc, F. Dupuch, and C. Desgranges Extracellular Adenosine Induces Apoptosis of Human Arterial Smooth Muscle Cells via A2b-Purinoceptor Circ. Res., January 7, 2000; 86(1): 76 - 85. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, M. Rosselli, P. J. Keller, and E. K. Jackson Estradiol Inhibits Smooth Muscle Cell Growth in Part by Activating the cAMP-Adenosine Pathway Hypertension, January 1, 2000; 35(1): 262 - 266. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, and E. K. Jackson Cyclic AMP-Adenosine Pathway Induces Nitric Oxide Synthesis in Aortic Smooth Muscle Cells Hypertension, January 1, 1998; 31(1): 296 - 302. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Adenosine Inhibits Growth of Human Aortic Smooth Muscle Cells Via A2B Receptors Hypertension, January 1, 1998; 31(1): 516 - 521. [Abstract] [Full Text] [PDF]

				I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]